Outlook Therapeutics, Inc. OTLK
0.46 USD +0.02 (+5.25%)
At closeNov 9, 2026, 7:30 PM EST
0.46 0.00 -0.02%
After hours · Nov 9, 7:30 PM ET
0.435 Day range 0.4661
0.161 52-week range 2.54
- YTD
- -70.93%
- 1 year
- -61.40%
Revenue & Expenses
Latest period ending Sep 30, 2025 · select a line to chart its full history
Income statement
| Fiscal year | FY 2025 Sep 30, 2025 | FY 2024 Sep 30, 2024 | FY 2023 Sep 30, 2023 | FY 2022 Sep 30, 2022 | FY 2021 Sep 30, 2021 |
|---|---|---|---|---|---|
| 1.41M | 0 | 0 | 0 | 0 | |
| 57.20K | 0 | 0 | 0 | 0 | |
| -67.06M | -71.70M | -53.13M | -63.07M | -51.73M | |
| -62.42M | -75.37M | -58.98M | -66.05M | -53.16M | |
| -1.79 | -4.06 | -4.72 | -6.20 | -7.00 |
Balance sheet
| Fiscal year | FY 2025 Sep 30, 2025 | FY 2024 Sep 30, 2024 | FY 2023 Sep 30, 2023 | FY 2022 Sep 30, 2022 | FY 2021 Sep 30, 2021 |
|---|---|---|---|---|---|
| 8.08M | 14.93M | 23.39M | 17.40M | 14.48M | |
| 18.58M | 28.82M | 32.30M | 28.53M | 22.81M | |
| 50.77M | 101.90M | 46.74M | 19.79M | 18.20M | |
| 30.19M | 29.74M | 35.56M | 10.96M | 11.90M | |
| -32.19M | -73.08M | -14.44M | 8.74M | 4.61M |
Cash flow
| Fiscal year | FY 2025 Sep 30, 2025 | FY 2024 Sep 30, 2024 | FY 2023 Sep 30, 2023 | FY 2022 Sep 30, 2022 | FY 2021 Sep 30, 2021 |
|---|---|---|---|---|---|
| -51.83M | -68.79M | -42.97M | -56.67M | -54.25M | |
| 44.98M | 60.33M | 48.97M | 59.59M | 56.19M | |
| -6.84M | -8.46M | 6.00M | 2.92M | 1.94M |